Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy

NCT04809727 — Not applicable, Completed, 88 participants, Tanta University

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

Registry	NCT04809727, acronym HSTH
Status	Completed
Phase	Not applicable
Study type	Interventional; na, single group, masking: none, diagnostic
Enrollment	88 (Actual)
Sponsor	Tanta University (Other)
Conditions	CIN, Cancer of Cervix, Cervicitis
Interventions	Cervical biopsy (Procedure)
Dates	start 2017-12-01, primary completion 2020-12-31, completion 2021-01-31, first posted 2021-03-22, last updated 2021-04-06
Locations	1 site in Egypt

-Summary

Supracervical hysterectomy is widely common and had many complications either immediate or delayed. In these patients bleeding, infection, chronic pelvic pain are common. In these patients cervical biopsy was done and histopathological examinations were done to evaluate the pathology in these patients.

Expand all sections · Collapse all

+Detailed description

* Study design and settings: Cross sectional descriptive studies conducted from December 2017 till January 2021.
* Patients: 80 patients with supracervical hysterectomy recruited at Tanta University Hospital, gynecology clinics will be recruited according inclusion and exclusion criteria. Inclusion criteria include all symptomatizing patients following supracervical hysterectomy, of any age, of any complaints. The exclusion criteria were patients with total hysterectomy, hysterectomies for malignant indications, and refusal to participate.
* Methods: All patients' demographic data, history, indication of hysterectomy, duration since operation, postoperative complications and their main complaint.

Intervention: under general anesthesia cervical biopsy (4 quadrants) were taken from all patients and was sent for histopathological examinations.

+Arms and interventions

Arm	Type	Interventions	Description
Biopsy	Experimental	Procedure: Cervical biopsy	four quadrant biopsy

Cervical biopsy (Procedure): 4 quadrant biopsy

+Outcome measures

Primary outcomes

Detection of cervical neoplasia or cancer incidence [1 year]: Detection of number of cases diagnosed with cervical Cervical intraepithelial neoplasia, or malignancy by histopathological examination
Detection of chronic cervicitis incidence [1 year]: Detection of number of cases diagnosed with inflammatory cells and other markers of inflammation

+Eligibility

Sex: Female, ages: 40 Years to any

Inclusion Criteria:

* all symptomatizing patients following supracervical hysterectomy,

Exclusion Criteria:

* with total hysterectomy,
* hysterectomies for malignant indications,
* refusal to participate.

+Locations (1)

Facility	City	Country	Status
Ayman Shehata Dawood	Tanta, Gharbia Governorate	Egypt

My Notes

Public

To Read Reading Read